Work

A Phase 2, Randomized, Controlled, Dose-Ranging Study Evaluating Crisaborole Topical Ointment, 0.5% and 2% in Adolescents With Mild to Moderate Atopic Dermatitis.

Year: 2015
Type: article
Source: PubMed
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2418638731
FWCI: 10.65
Cites:
Cited by: 63
Related to: 10